Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes

Journal of Clinical Investigation

Volumn 97, Issue 12, 1996, Pages 2772-2783

  Aanstoot, Henk Jan ^a,g   Kang, Sang Mo ^a   Kim, John ^a   Lindsay, LeAnn ^a   Roll, Ursula ^a   Knip, Mikael ^b   Atkinson, Mark ^c   Mose Larsen, Peter ^d   Fey, Stephen ^d   Ludvigsson, Johnny ^e   Landin, Mona ^f   Bruining, Jan ^g   Maclaren, Noel ^c   Åkerblom, Hans K ^h   Bækkeskov, Steinunn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoantibodies; Autoantigen; Insulin dependent diabetes mellitus; Islet; Membrane glycoprotein

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; AUTOANTIBODY; GLIMA 38 ANTIGEN; GLUTAMATE DECARBOXYLASE; MEMBRANE ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MOLECULAR WEIGHT; PROTEIN-TYROSINE-PHOSPHATASE; RATS;

EID: 0029977765     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118732     Document Type: Article

References (44)

1. Bækkeskov, S., and B. Hansen, editors. 1990. Human Diabetes. Genetic, Environmental and Autoimmune Etiology. Curr. Top. Microbiol. Immunol. Vol. 164. 198 pp.
2. Srikanta, S., O.P. Ganda, R.A. Jackson, R.E. Gleason, A. Kaldany, M.R. Garovoy, E.L. Milford, C.B. Carpenter, J.S. Soeldner, and G.S. Eisenbarth. 1983. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann. Intern. Med. 99:320-327.
3. Gorsuch, A.N., K.M. Spencer, J. Lister, J.M. McNally, B.M. Dean, G.F. Bottazzo, and A.H. Cudworth. 1981. Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet. ii:1363-1365.
4. Cooke. A. 1990. An overview on possible mechanisms of destruction of the insulin-producing beta cell. Curr. Top. Microbiol. Immunol. 164:125-142.
5. Bækkeskov, S., H.J. Aanstoot, S. Christgau, A. Reetz, M. Solimena, M. Cascalho, F. Folli, and H. Richter-Olesen. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (Lond.). 347:151-156.
6. Bækkeskov, S., J.H. Nielsen, B. Marner, T. Bilde, J. Ludvigsson, and Å. Lernmark. 1982. Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human pancreatic islet cell proteins. Nature (Lond.). 298: 167-169.
7. Christie, M.R., G. Vohra, P. Champagne, D. Daneman, and T.L. Delovitch. 1990. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J. Exp. Med. 172:789-794.
8. r tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96:1506-1511.
9. Passini, N., J.D. Larigan, S. Genovese, E. Appella, F. Sinigaglia, and L. Rogge. 1995. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc. Natl. Acad. Sci. USA. 92:9412-9416.
10. Richter, W., K.M. Jury, D. Loeffler, B.J. Manfras, T.E. Eiermann, and B.O. Boehm. 1995. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus. Eur. J. Immunol. 25:1703-1712.
11. Castano, L., E. Russo, L. Zhou, M.A. Lipes, and G.A. Eisenbarth. 1991. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J. Clin. Endocrinol. & Metab. 73:1197-1201.
12. Karounos, D.G., and J.W. Thomas. 1990. Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes. 39:1085-1090.
13. Karjalainen, J.K., J.M. Martin, M. Knip, J. Ilonen, B.H. Robinson, E. Savilahti, H.K. Åkerbloom, and H.-M. Dosch. 1992. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N. Engl. J. Med. 327:302-307.
14. Okada, Y., H. Taniguchi, and C. Shimada. 1976. High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science (Wash. DC). 194:620-622.
15. Richter, W., Y. Shi, and S. Bækkeskov. 1993. Autoreactive epitopes in glutamic acid decarboxylase defined by diabetes-associated human monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 90:2832-2836.
16. Mauch, L., C.C. Abney, H. Berg, W.A. Scherbaum, B. Liedvogel, and W. Northemann. 1993. Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus patients. Eur. J. Biochem. 212: 597-603.
17. Rabin, D.U., S.M. Pleasic, R. Palmer-Crocker, and J.A. Shapiro. 1992. Cloning and expression of IDDM-specific human autoantigens. Diabetes. 41: 183-186.
18. Ko, I., S. Ihm, and J.W. Yoon. 1991. Studies on autoimmunity for initiation of beta-cell destruction. VII. Pancreatic beta cell dependent autoantibody to a 38kD protein precedes the clinical onset of diabetes in BB rats. Diabetologia. 34:548-554.
19. Arden, S.D., B.O. Roep, P.I. Neophytou, E.F. Usac, G. Duinkerken, R.R.P. de Vries, and J.C. Mutton. 1996. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J. Clin Invest. 97:551-561.
20. Honeyman, M.C., D.S. Cram, and L.C. Harrison. 1993. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes. 42:626-630.
21. Bækkeskov, S., G. Warnock, M. Christie, R.V. Rajolte, P.M. Larson, and S. Fey. 1989. Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes. 38:1133-1141.
22. r-64000 islet cell protein in Swedish children with newly diagnosed Type I (insulin-dependent) diabetes. Diabetologia. 31:597-602.
23. 65 combined with islet cell cytoplasmic anybodies for predicting IDDM in a childhood population. Diabetologia. 37:917-924.
24. Schmidli, R.S., P.G. Colman, E. Bonifacio, G.F. Botazzo, and L.C. Harrison. 1994. High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes. 43:1005-1009.
25. Efrat, S., S. Linde, H. Kofod, D. Spector, M. Delannoy, S. Grant, D. Hanahan, and S. Bækkeskov. 1988. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. USA. 85: 9037-9041.
26. Radvanyi, F., S. Christgau, S. Bækkeskov, C. Jolicoeur, and D. Hanahan. 1993. Pancreatic β cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines. Mol. Cell. Biol. 13:4223-4232.
27. Powers, A.C., S. Efrat, S. Mojsov, D. Spector, J.F. Habener, and D. Hanahan. 1990. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor. Diabetes. 339:406-414.
28. Martinez de la Escalera, G., A.L. Choi, and R.I. Weiner. 1990. Generation and synchronization of gonadotropin-releasing hormone (GnRH) pulses: intrinsic properties of the GT1-1 GnRH neuronal cell line. Proc. Natl. Acad. Sci. USA. 89:1852-1855.
29. Preis, P.N., S. Hideyuki, L. Nádasdi, G. Hochhaus, V. Levin, and W. Sadée. 1988. Neuronal cell differentiation of human neuroblastoma cells by relinoic acid plus herbimycin A. Cancer Res. 48:6530-6534.
30. Okey, A.B., G.P. Bondy, M.E. Mason, D.W. Nebert, C.J. Forster-Gibson, J. Muncan, and M.J. Dufresne. 1980. Temperature-dependent cytosolto-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J. Biol. Chem. 255:11415-11422.
31. Fey, S.J., P. Mose-Larsen, and N.L. Biskjaer. 1984. The Protein Variation in Basal Cells and Certain Basal Cell Related Benign and Malignant Diseases. Faculty of Natural Science, Århus University, Århus, Denmark.
32. Landin-Olsson, M., K.O. Nilsson, Å. Lernmark, and G. Sundkvist. 1990. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia. 33:561-568.
33. Bruining, G.F., J.L. Molenaar, D.E. Grobbee, A. Hofman, G.J. Scheffer, H.A. Bruining, A.M. De Bruyn, and H.A. Valkenburg. 1989. Ten year follow-up study of islet-cell antibodies and childhood diabetes. Lancet. i:1100-1103.
34. Karjalainen, J.K. 1990. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of the disease. Diabetes. 39: 1144-1150.
35. Lernmark, Å., J.L. Molenaar, W.A.M. Van Beers, Y. Yamaguchi, S. Nagataki, J. Ludvigsson, and N.K. Maclaren. 1991. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. Diabetologia. 34:534-535.
36. Greenbaum, C.J., J.P. Palmer, S. Nagataki, Y. Yamaguchi, J.L. Molenaar, W.A.M. Van Beers, N.K. Maclaren, Å. Lernmark, and Participating Laboratories. 1992. Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes. 41:1570-1574.
37. Christgau, S., H. Schierbeck, H.J. Aanstoot, L. Aagaard, K. Begley, H. Kofod, K. Hejnaes, and S. Bækkeskov. 1991. Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble. J. Biol. Chem. 266:21257-21264.
38. 2-terminal domain. J. Cell Biol. 118:309-320.
39. r human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J. Clin. Invest. 79:926-934.
40. r auroantibodies as predictors of insulin-dependent diabetes. Lancet. 335: 1357-1360.
41. Svejgaard, A., and L.P. Ryder. 1989. HLA and insulin-dependent diabetes: an overview. Genet. Epidemiol. 6:1-14.
42. Nayak, R.C., M.A.K. Omar, A. Rabizadeh, S. Srikanta, and G.S. Eisenbarth. 1985. "Cytoplasmic" islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes. 34:617-619.
43. Schütte, J., D. Viallet, M. Nau, S. Segal, J. Fedorko, and J. Minna. 1989. jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell. 59:987-997.
44. Palmer, J.P., C.M. Asplin, P. Clemens, K. Lyen, O. Tatpati, P.K. Raghu, and T.L. Paquette. 1983. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science (Wash. DC). 222:1337-1339.